International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.

Cutting Edge Diagnostic Methods for Early Diagnoses of Breast Cancer

Author(s) Ekta. A Andriyas, Abhishek Verma, Arun Kumar Saxena, Munzali Hamishu Umar, Imran Hussain
Country India
Abstract Breast cancer has a lengthy history; the Egyptians were the first to record cases of the disease over 3500 years ago, around 1500 B.C. Worldwide, breast cancer is the most common cancer and the leading cause of cancer-related deaths in women. Asia is the region responsible for 43% of newly diagnosed cases and 50% of all breast cancer deaths globally. Lung cancer is no longer the primary cause of cancer incidence worldwide; breast cancer in women has surpassed it entirely, accounting for 11.7% of all cancer cases with a projected 2.3 million new cases in 2020. With a prevalence incidence of 25.8 instances per 100,000 people, breast cancer is the most frequent cancer in India. In 2020, it will be responsible for 13.6% of all new cancer cases and around 13.3 fatalities per 100,000 people. In 2020, there was 13.3 fatalities per 100,000 persons. When breast cancer is discovered at stage IV as opposed to stage I, the survival rate drops by 2.7 times, and in 2020, about 90,408 Indian women lost their lives as a consequence. In developing nations, breast cancer remains the leading cause of cancer-related mortality for women. The consensus on the causes of cancer is that smoking and alcohol consumption are to blame. However, the reality remains that it is diverse, and if identified early on, it can be treated favorably with a better-than-expected prognosis and even a lower death rate. Additionally, a wealth of scientific evidence supports the notion that 30% of cancers are curable if identified early and treated promptly, 40% are preventable, and the remaining 30% of advanced cancers are treated with palliative care due to the necessity of effective pain relief measures. According to the American Cancer Society, 281,550 women are expected to receive a breast cancer diagnosis in 2021, and 43,600 women are expected to lose their lives to the disease in the US. Early identification of diseases is essential for Individuals with smaller tumors at the time of diagnosis have a much lower chance of dying and a greater survival rate, indicating an effective therapy and expected prognosis. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers.
Keywords early Diagnosis, Breast Cancer, Malignancy, Cancer Markers
Field Medical / Pharmacy
Published In Volume 6, Issue 3, May-June 2024
Published On 2024-06-08
Cite This Cutting Edge Diagnostic Methods for Early Diagnoses of Breast Cancer - Ekta. A Andriyas, Abhishek Verma, Arun Kumar Saxena, Munzali Hamishu Umar, Imran Hussain - IJFMR Volume 6, Issue 3, May-June 2024. DOI 10.36948/ijfmr.2024.v06i03.21946
DOI https://doi.org/10.36948/ijfmr.2024.v06i03.21946
Short DOI https://doi.org/gtzjpn

Share this